25 XP   0   0   10

GeoVax Labs Inc
Buy, Hold or Sell?

Let's analyse Geovax together

PenkeI guess you are interested in GeoVax Labs Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of GeoVax Labs Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about GeoVax Labs Inc

I send you an email if I find something interesting about GeoVax Labs Inc.

Quick analysis of Geovax (30 sec.)










What can you expect buying and holding a share of Geovax? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$2.65
Expected worth in 1 year
$-6.94
How sure are you?
32.5%

+ What do you gain per year?

Total Gains per Share
$-9.59
Return On Investment
-631.0%

For what price can you sell your share?

Current Price per Share
$1.52
Expected price per share
$0 - $1.82
How sure are you?
50%

1. Valuation of Geovax (5 min.)




Live pricePrice per Share (EOD)

$1.52

Intrinsic Value Per Share

$-19,098.34 - $-6,631.34

Total Value Per Share

$-19,095.68 - $-6,628.68

2. Growth of Geovax (5 min.)




Is Geovax growing?

Current yearPrevious yearGrowGrow %
How rich?$5.7m$24.4m-$10.6m-77.8%

How much money is Geovax making?

Current yearPrevious yearGrowGrow %
Making money-$6.4m-$3.5m-$2.9m-45.5%
Net Profit Margin-1,826.6%905.2%--

How much money comes from the company's main activities?

3. Financial Health of Geovax (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#740 / 1016

Most Revenue
#680 / 1016

Most Profit
#466 / 1016

Most Efficient
#853 / 1016

What can you expect buying and holding a share of Geovax? (5 min.)

Welcome investor! Geovax's management wants to use your money to grow the business. In return you get a share of Geovax.

What can you expect buying and holding a share of Geovax?

First you should know what it really means to hold a share of Geovax. And how you can make/lose money.

Speculation

The Price per Share of Geovax is $1.52. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Geovax.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Geovax, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.65. Based on the TTM, the Book Value Change Per Share is $-2.40 per quarter. Based on the YOY, the Book Value Change Per Share is $2.89 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Geovax.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-3.50-229.9%-3.21-210.9%-0.79-52.1%-1.05-69.2%-0.68-44.8%
Usd Book Value Change Per Share-1.54-101.6%-2.40-157.8%2.89190.1%0.1610.3%0.042.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-1.54-101.6%-2.40-157.8%2.89190.1%0.1610.3%0.042.5%
Usd Price Per Share0.36-0.52-0.93-1.55-0.78-
Price to Earnings Ratio-0.03--0.04--0.92--1.26--0.63-
Price-to-Total Gains Ratio-0.23--0.24-0.35-2.35-1.18-
Price to Book Ratio0.14-0.10-0.49-0.63-0.32-
Price-to-Total Gains Ratio-0.23--0.24-0.35-2.35-1.18-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.52
Number of shares657
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-2.400.16
Usd Total Gains Per Share-2.400.16
Gains per Quarter (657 shares)-1,575.48102.61
Gains per Year (657 shares)-6,301.91410.46
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-6302-63120410400
20-12604-126140821810
30-18906-18916012311220
40-25208-25218016421630
50-31510-31520020522040
60-37811-37822024632450
70-44113-44124028732860
80-50415-50426032843270
90-56717-56728036943680
100-63019-63030041054090

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.040.00.00.0%2.086.01.02.2%
Book Value Change Per Share0.04.00.00.0%4.08.00.033.3%7.013.00.035.0%13.027.00.032.5%27.061.01.030.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.089.00.0%
Total Gains per Share0.04.00.00.0%4.08.00.033.3%7.013.00.035.0%13.027.00.032.5%27.061.01.030.3%

Fundamentals of Geovax

About GeoVax Labs Inc

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company is developing GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine. In addition, it is developing GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of Zika; GEO-MM02 treatment for malaria; other infectious disease vaccines for the treatment of fever viruses, such as Ebola, Sudan, and Marburg; GEO-LM01 for the treatment of Lassa fever. It has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; U.S. Department of Defense; Emory University; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is headquartered in Smyrna, Georgia.

Fundamental data was last updated by Penke on 2024-04-11 10:13:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of GeoVax Labs Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Geovax earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Geovax to the Biotechnology industry mean.
  • A Net Profit Margin of -7,306.6% means that $-73.07 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of GeoVax Labs Inc:

  • The MRQ is -7,306.6%. The company is making a huge loss. -2
  • The TTM is -1,826.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-7,306.6%TTM-1,826.6%-5,479.9%
TTM-1,826.6%YOY905.2%-2,731.8%
TTM-1,826.6%5Y-1,160.0%-666.6%
5Y-1,160.0%10Y-829.4%-330.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-7,306.6%-197.2%-7,109.4%
TTM-1,826.6%-210.4%-1,616.2%
YOY905.2%-279.3%+1,184.5%
5Y-1,160.0%-436.8%-723.2%
10Y-829.4%-599.3%-230.1%
1.1.2. Return on Assets

Shows how efficient Geovax is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Geovax to the Biotechnology industry mean.
  • -81.8% Return on Assets means that Geovax generated $-0.82 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of GeoVax Labs Inc:

  • The MRQ is -81.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -43.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-81.8%TTM-43.9%-37.9%
TTM-43.9%YOY-12.1%-31.7%
TTM-43.9%5Y-51.0%+7.1%
5Y-51.0%10Y-70.1%+19.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-81.8%-13.6%-68.2%
TTM-43.9%-12.9%-31.0%
YOY-12.1%-11.9%-0.2%
5Y-51.0%-14.2%-36.8%
10Y-70.1%-16.2%-53.9%
1.1.3. Return on Equity

Shows how efficient Geovax is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Geovax to the Biotechnology industry mean.
  • -131.7% Return on Equity means Geovax generated $-1.32 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of GeoVax Labs Inc:

  • The MRQ is -131.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -68.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-131.7%TTM-68.8%-63.0%
TTM-68.8%YOY-15.5%-53.3%
TTM-68.8%5Y-34.8%-33.9%
5Y-34.8%10Y-57.0%+22.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-131.7%-17.0%-114.7%
TTM-68.8%-16.1%-52.7%
YOY-15.5%-15.4%-0.1%
5Y-34.8%-20.0%-14.8%
10Y-57.0%-21.1%-35.9%

1.2. Operating Efficiency of GeoVax Labs Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Geovax is operating .

  • Measures how much profit Geovax makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Geovax to the Biotechnology industry mean.
  • An Operating Margin of -7,404.1% means the company generated $-74.04  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of GeoVax Labs Inc:

  • The MRQ is -7,404.1%. The company is operating very inefficient. -2
  • The TTM is -1,851.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-7,404.1%TTM-1,851.0%-5,553.1%
TTM-1,851.0%YOY907.5%-2,758.5%
TTM-1,851.0%5Y-1,173.3%-677.7%
5Y-1,173.3%10Y-836.9%-336.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-7,404.1%-286.1%-7,118.0%
TTM-1,851.0%-224.4%-1,626.6%
YOY907.5%-288.4%+1,195.9%
5Y-1,173.3%-475.2%-698.1%
10Y-836.9%-624.7%-212.2%
1.2.2. Operating Ratio

Measures how efficient Geovax is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 74.04 means that the operating costs are $74.04 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of GeoVax Labs Inc:

  • The MRQ is 74.041. The company is inefficient in keeping operating costs low. -1
  • The TTM is 18.510. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ74.041TTM18.510+55.531
TTM18.510YOY-9.075+27.585
TTM18.5105Y12.674+5.837
5Y12.67410Y12.098+0.576
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ74.0412.997+71.044
TTM18.5103.247+15.263
YOY-9.0753.766-12.841
5Y12.6745.675+6.999
10Y12.0987.857+4.241

1.3. Liquidity of GeoVax Labs Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Geovax is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.24 means the company has $2.24 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of GeoVax Labs Inc:

  • The MRQ is 2.240. The company is able to pay all its short-term debts. +1
  • The TTM is 3.727. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ2.240TTM3.727-1.487
TTM3.727YOY6.976-3.249
TTM3.7275Y11.365-7.637
5Y11.36510Y8.085+3.280
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.2403.930-1.690
TTM3.7274.251-0.524
YOY6.9765.436+1.540
5Y11.3656.045+5.320
10Y8.0856.363+1.722
1.3.2. Quick Ratio

Measures if Geovax is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Geovax to the Biotechnology industry mean.
  • A Quick Ratio of 1.83 means the company can pay off $1.83 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of GeoVax Labs Inc:

  • The MRQ is 1.833. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.308. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.833TTM3.308-1.475
TTM3.308YOY6.726-3.418
TTM3.3085Y11.189-7.880
5Y11.18910Y7.891+3.298
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8333.629-1.796
TTM3.3084.065-0.757
YOY6.7265.397+1.329
5Y11.1895.993+5.196
10Y7.8916.277+1.614

1.4. Solvency of GeoVax Labs Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Geovax assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Geovax to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.38 means that Geovax assets are financed with 37.9% credit (debt) and the remaining percentage (100% - 37.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of GeoVax Labs Inc:

  • The MRQ is 0.379. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.294. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.379TTM0.294+0.086
TTM0.294YOY0.204+0.090
TTM0.2945Y1.203-0.909
5Y1.20310Y1.028+0.174
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3790.332+0.047
TTM0.2940.334-0.040
YOY0.2040.268-0.064
5Y1.2030.366+0.837
10Y1.0280.390+0.638
1.4.2. Debt to Equity Ratio

Measures if Geovax is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Geovax to the Biotechnology industry mean.
  • A Debt to Equity ratio of 61.1% means that company has $0.61 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of GeoVax Labs Inc:

  • The MRQ is 0.611. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.456. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.611TTM0.456+0.155
TTM0.456YOY0.267+0.189
TTM0.4565Y0.242+0.214
5Y0.24210Y0.282-0.040
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6110.381+0.230
TTM0.4560.390+0.066
YOY0.2670.334-0.067
5Y0.2420.434-0.192
10Y0.2820.466-0.184

2. Market Valuation of GeoVax Labs Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Geovax generates.

  • Above 15 is considered overpriced but always compare Geovax to the Biotechnology industry mean.
  • A PE ratio of -0.03 means the investor is paying $-0.03 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of GeoVax Labs Inc:

  • The EOD is -0.109. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.026. Based on the earnings, the company is expensive. -2
  • The TTM is -0.043. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.109MRQ-0.026-0.083
MRQ-0.026TTM-0.043+0.017
TTM-0.043YOY-0.924+0.881
TTM-0.0435Y-1.263+1.221
5Y-1.26310Y-0.633-0.630
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.109-2.315+2.206
MRQ-0.026-2.560+2.534
TTM-0.043-2.664+2.621
YOY-0.924-4.122+3.198
5Y-1.263-6.258+4.995
10Y-0.633-6.108+5.475
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of GeoVax Labs Inc:

  • The EOD is -0.080. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.019. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.055. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.080MRQ-0.019-0.061
MRQ-0.019TTM-0.055+0.036
TTM-0.055YOY-0.715+0.660
TTM-0.0555Y-1.366+1.311
5Y-1.36610Y-0.685-0.681
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.080-3.067+2.987
MRQ-0.019-3.251+3.232
TTM-0.055-3.545+3.490
YOY-0.715-5.595+4.880
5Y-1.366-8.315+6.949
10Y-0.685-8.708+8.023
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Geovax is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.14 means the investor is paying $0.14 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of GeoVax Labs Inc:

  • The EOD is 0.573. Based on the equity, the company is cheap. +2
  • The MRQ is 0.136. Based on the equity, the company is cheap. +2
  • The TTM is 0.098. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.573MRQ0.136+0.437
MRQ0.136TTM0.098+0.038
TTM0.098YOY0.489-0.391
TTM0.0985Y0.632-0.534
5Y0.63210Y0.316+0.316
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.5731.905-1.332
MRQ0.1362.111-1.975
TTM0.0982.095-1.997
YOY0.4892.836-2.347
5Y0.6323.443-2.811
10Y0.3163.794-3.478
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of GeoVax Labs Inc.

3.1. Institutions holding GeoVax Labs Inc

Institutions are holding 15.732% of the shares of GeoVax Labs Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30Vanguard Group Inc2.23560728443-2542-0.3477
2023-09-30BlackRock Inc1.2689041344400
2023-09-30Geode Capital Management, LLC0.530601728951450.0839
2023-09-30State Street Corporation0.300609794200
2023-09-30Morgan Stanley - Brokerage Accounts0.154105019700
2023-09-30Northern Trust Corp0.10503421400
2023-09-30Welch & Forbes LLC0.05220.00011699400
2023-09-30Tower Research Capital LLC0.03220.000210504-58-0.5491
2023-09-30Wells Fargo & Co0.01404568-122-2.6013
2023-12-31Global Retirement Partners, LLC.0.0012040100
2023-09-30Royal Bank of Canada0.000205000
2023-09-30JPMorgan Chase & Co0.0001032320
2023-12-31UBS Group AG000-19019-100
2023-09-30GSA Capital Partners LLP000-11328-100
2023-09-30Virtu Financial LLC000-27097-100
2023-12-31Advisor Group Holdings, Inc.000-3000-100
2023-09-30TWO SIGMA SECURITIES, LLC000-36805-100
Total 4.69470.00031529684-99794-6.5%

3.2. Funds holding GeoVax Labs Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30BlackRock Extended Mkt Composite0.2880.00039385400
2024-02-29Vanguard Total Stock Mkt Idx Inv1.3502932610.0034
2023-12-31Northern Trust Extended Eq Market Idx0.06220.00012026700
2023-12-31NT Ext Equity Mkt Idx Fd - L0.06220.00012026700
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.88560.00011923910.0052
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.04280.00011394700
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.03440.000111201210.1878
2023-12-31SSgA U.S. Extended Market Index Class I0.0310.00011010000
2024-02-29Fidelity Extended Market Index0.36740.0001798130.0376
2024-03-31BlackRock Extended Equity Market K0.25140.0001546230.055
2023-12-31SSgA U.S. Total Market Index Strategy0.008902913-67-2.2483
2024-02-29Fidelity Series Total Market Index0.09540207210.0483
2024-03-31Extended Equity Market Fund M0.0310.0001674-1-0.1481
2024-03-31State St US Extended Mkt Indx NL Cl C0.0310.000167300
2024-02-29Fidelity Total Market Index0.0255055400
2023-12-31NT Ext Eq Mkt Indx Fd DC Lending Tier 50.00140.000145120.4454
2024-02-29Fidelity Nasdaq Composite Index0.0189041010.2445
2024-02-29Spartan Extended Market Index Pool E0.017036910.2717
2024-02-29Spartan Total Market Index Pool E0.0062013510.7463
2024-02-29Fidelity U.S. Equity Index Ins Trust0.00040990
Total 3.61070.0014239904-240.0%

3.3. Insider Transactions

Insiders are holding 1.689% of the shares of GeoVax Labs Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-02-21David A DoddBUY5202.15
2023-12-22Kelly T Jr. MckeeBUY4625.4
2023-09-25Kelly T Jr. MckeeBUY6437.8
2023-08-25David A DoddBUY23398.55
2023-08-18Mark ReynoldsBUY6667.8
2023-04-24David A DoddBUY21339.6
2023-04-20Mark ReynoldsBUY5339.45

4. Summary

4.1. Key Performance Indicators

The key performance indicators of GeoVax Labs Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.545-2.398+55%2.890-153%0.156-1089%0.037-4248%
Book Value Per Share--2.6536.319-58%4.347-39%2.792-5%1.538+73%
Current Ratio--2.2403.727-40%6.976-68%11.365-80%8.085-72%
Debt To Asset Ratio--0.3790.294+29%0.204+86%1.203-68%1.028-63%
Debt To Equity Ratio--0.6110.456+34%0.267+128%0.242+153%0.282+117%
Dividend Per Share----0%-0%-0%-0%
Eps---3.495-3.206-8%-0.791-77%-1.052-70%-0.681-81%
Free Cash Flow Per Share---4.740-2.903-39%-1.069-77%-376.735+7848%-190.072+3910%
Free Cash Flow To Equity Per Share---2.870-2.435-15%2.892-199%100298.722-100%50147.830-100%
Gross Profit Margin---793181.743-198294.686-75%1.000-79318274%-39658.137-95%-19828.568-98%
Intrinsic Value_10Y_max---6631.336--------
Intrinsic Value_10Y_min---19098.336--------
Intrinsic Value_1Y_max---747.462--------
Intrinsic Value_1Y_min---2425.105--------
Intrinsic Value_3Y_max---2182.600--------
Intrinsic Value_3Y_min---6886.760--------
Intrinsic Value_5Y_max---3541.534--------
Intrinsic Value_5Y_min---10876.172--------
Market Cap3301911.200+76%784203.9101135031.975-31%11419594.603-93%9169578.382-91%4588373.503-83%
Net Profit Margin---73.066-18.266-75%9.052-907%-11.600-84%-8.294-89%
Operating Margin---74.041-18.510-75%9.075-916%-11.733-84%-8.369-89%
Operating Ratio--74.04118.510+300%-9.075+112%12.674+484%12.098+512%
Pb Ratio0.573+76%0.1360.098+39%0.489-72%0.632-78%0.316-57%
Pe Ratio-0.109-321%-0.026-0.043+65%-0.924+3477%-1.263+4792%-0.633+2351%
Price Per Share1.520+76%0.3610.523-31%0.925-61%1.549-77%0.776-53%
Price To Free Cash Flow Ratio-0.080-321%-0.019-0.055+188%-0.715+3655%-1.366+7074%-0.685+3496%
Price To Total Gains Ratio-0.984-321%-0.234-0.242+4%0.354-166%2.351-110%1.180-120%
Quick Ratio--1.8333.308-45%6.726-73%11.189-84%7.891-77%
Return On Assets---0.818-0.439-46%-0.121-85%-0.510-38%-0.701-14%
Return On Equity---1.317-0.688-48%-0.155-88%-0.348-74%-0.570-57%
Total Gains Per Share---1.545-2.398+55%2.890-153%0.156-1089%0.037-4248%
Usd Book Value--5763338.00013727808.500-58%24401845.500-76%11326575.800-49%5971548.875-3%
Usd Book Value Change Per Share---1.545-2.398+55%2.890-153%0.156-1089%0.037-4248%
Usd Book Value Per Share--2.6536.319-58%4.347-39%2.792-5%1.538+73%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---3.495-3.206-8%-0.791-77%-1.052-70%-0.681-81%
Usd Free Cash Flow---10296894.000-6305646.250-39%-4757552.000-54%-2388888133.850+23100%-1198146291.400+11536%
Usd Free Cash Flow Per Share---4.740-2.903-39%-1.069-77%-376.735+7848%-190.072+3910%
Usd Free Cash Flow To Equity Per Share---2.870-2.435-15%2.892-199%100298.722-100%50147.830-100%
Usd Market Cap3301911.200+76%784203.9101135031.975-31%11419594.603-93%9169578.382-91%4588373.503-83%
Usd Price Per Share1.520+76%0.3610.523-31%0.925-61%1.549-77%0.776-53%
Usd Profit---7592408.000-6433537.000-15%-3503092.500-54%-3182276.600-58%-1926748.275-75%
Usd Revenue--103912.00025978.000+300%-+100%174448.350-40%191694.825-46%
Usd Total Gains Per Share---1.545-2.398+55%2.890-153%0.156-1089%0.037-4248%
 EOD+5 -3MRQTTM+7 -27YOY+3 -315Y+6 -2810Y+8 -26

4.2. Fundamental Score

Let's check the fundamental score of GeoVax Labs Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.109
Price to Book Ratio (EOD)Between0-10.573
Net Profit Margin (MRQ)Greater than0-73.066
Operating Margin (MRQ)Greater than0-74.041
Quick Ratio (MRQ)Greater than11.833
Current Ratio (MRQ)Greater than12.240
Debt to Asset Ratio (MRQ)Less than10.379
Debt to Equity Ratio (MRQ)Less than10.611
Return on Equity (MRQ)Greater than0.15-1.317
Return on Assets (MRQ)Greater than0.05-0.818
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of GeoVax Labs Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5029.573
Ma 20Greater thanMa 501.834
Ma 50Greater thanMa 1002.110
Ma 100Greater thanMa 2003.573
OpenGreater thanClose1.550
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Gross Profit  -163146-170-170-179982



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets9,283
Total Liabilities3,520
Total Stockholder Equity5,763
 As reported
Total Liabilities 3,520
Total Stockholder Equity+ 5,763
Total Assets = 9,283

Assets

Total Assets9,283
Total Current Assets7,886
Long-term Assets1,397
Total Current Assets
Cash And Cash Equivalents 6,453
Other Current Assets 1,433
Total Current Assets  (as reported)7,886
Total Current Assets  (calculated)7,886
+/-0
Long-term Assets
Property Plant Equipment 210
Long-term Assets Other 1,188
Long-term Assets  (as reported)1,397
Long-term Assets  (calculated)1,397
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities3,520
Long-term Liabilities0
Total Stockholder Equity5,763
Total Current Liabilities
Accounts payable 2,803
Other Current Liabilities 717
Total Current Liabilities  (as reported)3,520
Total Current Liabilities  (calculated)3,520
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock2
Retained Earnings -104,364
Other Stockholders Equity 110,125
Total Stockholder Equity (as reported)5,763
Total Stockholder Equity (calculated)5,763
+/-0
Other
Capital Stock2
Cash and Short Term Investments 6,453
Common Stock Shares Outstanding 1,964
Liabilities and Stockholders Equity 9,283
Net Debt -6,453
Net Invested Capital 5,763
Net Working Capital 4,366
Property Plant and Equipment Gross 890



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-31
> Total Assets 
7,538
7,180
11,806
11,161
11,161
8,443
8,836
3,917
3,917
2,198
2,191
371
172
0
0
0
19
0
102
35
19
78
95
2,829
2,396
1,997
1,328
984
3,246
2,527
4,012
3,858
3,056
2,769
2,432
4,275
4,316
3,835
3,848
2,993
2,358
2,068
2,134
1,813
1,645
2,837
2,290
2,036
1,478
2,130
2,044
1,961
2,840
2,173
1,521
1,053
1,333
3,359
2,664
1,998
1,332
796
339
675
610
304
990
496
490
840
371
623
642
473
343
817
469
831
958
11,756
10,394
21,115
19,817
18,340
11,797
16,855
33,241
38,570
31,348
27,404
21,249
16,201
9,283
9,28316,20121,24927,40431,34838,57033,24116,85511,79718,34019,81721,11510,39411,7569588314698173434736426233718404904969903046106753397961,3321,9982,6643,3591,3331,0531,5212,1732,8401,9612,0442,1301,4782,0362,2902,8371,6451,8132,1342,0682,3582,9933,8483,8354,3164,2752,4322,7693,0563,8584,0122,5273,2469841,3281,9972,3962,829957819351020190001723712,1912,1983,9173,9178,8368,44311,16111,16111,8067,1807,538
   > Total Current Assets 
5,981
5,723
4,566
0
3,553
1,662
1,297
0
1,352
336
379
0
0
0
0
0
19
0
0
0
19
78
95
2,611
2,126
1,741
1,086
756
3,031
2,322
3,272
3,363
2,802
2,530
2,210
4,014
3,881
3,053
2,948
2,137
1,602
1,331
1,348
1,004
1,418
2,634
2,110
1,879
1,344
2,014
1,946
1,794
2,698
2,048
1,401
926
1,225
3,243
2,555
1,896
1,237
709
259
602
544
241
934
446
448
802
339
596
620
448
320
796
447
810
938
11,735
10,235
20,961
19,657
18,160
11,629
16,637
32,038
36,137
28,939
25,989
19,827
14,800
7,886
7,88614,80019,82725,98928,93936,13732,03816,63711,62918,16019,65720,96110,23511,7359388104477963204486205963398024484469342415446022597091,2371,8962,5553,2431,2259261,4012,0482,6981,7941,9462,0141,3441,8792,1102,6341,4181,0041,3481,3311,6022,1372,9483,0533,8814,0142,2102,5302,8023,3633,2722,3223,0317561,0861,7412,1262,61195781900019000003793361,35201,2971,6623,55304,5665,7235,981
       Cash And Cash Equivalents 
4,228
4,015
2,261
0
2,683
757
308
0
725
67
48
0
0
0
0
0
8
0
0
0
8
78
95
2,589
2,088
1,713
1,009
732
1,990
2,121
3,134
2,785
2,191
1,971
1,823
3,417
3,516
2,603
1,808
1,426
1,079
542
668
567
1,168
2,240
1,817
1,584
1,036
1,751
1,881
1,721
2,514
2,010
1,372
862
1,102
3,147
2,476
1,821
1,060
670
215
511
454
167
823
344
313
571
191
511
260
176
216
569
283
222
711
11,581
9,884
20,843
19,539
18,107
11,424
16,258
30,902
34,677
27,613
23,850
17,789
12,687
6,453
6,45312,68717,78923,85027,61334,67730,90216,25811,42418,10719,53920,8439,88411,5817112222835692161762605111915713133448231674545112156701,0601,8212,4763,1471,1028621,3722,0102,5141,7211,8811,7511,0361,5841,8172,2401,1685676685421,0791,4261,8082,6033,5163,4171,8231,9712,1912,7853,1342,1211,9907321,0091,7132,0882,58995788000800000486772503087572,68302,2614,0154,228
       Net Receivables 
112
105
463
0
343
294
283
0
70
18
62
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
991
120
96
276
311
285
348
544
320
421
1,103
695
474
752
639
425
184
345
252
249
266
214
36
25
141
0
0
0
79
48
39
0
120
0
0
9
28
22
79
90
60
5
0
15
122
160
64
103
69
521
187
141
183
183
0
0
49
100
0
0
0
0
0
0
0
00000001004900183183141187521691036416012215056090792228900120039487900014125362142662492523451844256397524746951,103421320544348285311276961209910000000000000000062187002832943430463105112
       Inventory 
1,522
1,502
1,808
506
506
527
634
519
518
189
192
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-22
-79
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-49
0
0
0
0
0
0
0
0
00000000-4900000000000000000-79-220000000000000000000000000000000000000000000000000000001921895185196345275065061,8081,5021,522
       Other Current Assets 
119
102
34
21
21
84
71
38
38
62
77
0
169
0
0
0
11
0
0
0
9
0
0
22
38
28
77
24
50
82
43
302
299
274
38
53
45
29
38
16
49
38
41
12
67
48
41
47
42
49
29
48
44
38
29
64
45
48
40
75
57
39
44
82
62
74
111
12
76
226
148
70
238
112
39
123
95
68
40
13
169
118
118
53
205
280
1,136
1,460
1,326
2,139
2,038
2,113
1,433
1,4332,1132,0382,1391,3261,4601,13628020553118118169134068951233911223870148226761211174628244395775404845642938444829494247414867124138491638294553382742993024382502477283822009000110001690776238387184212134102119
   > Long-term Assets 
1,557
1,457
7,240
0
7,608
6,780
7,539
0
2,565
1,862
1,811
0
0
0
0
0
0
0
0
0
0
0
0
218
270
256
242
228
216
205
740
495
254
240
222
261
435
782
899
856
756
736
787
809
227
204
180
157
133
116
98
167
141
125
120
127
108
116
109
102
95
87
80
73
66
63
56
49
42
37
32
27
22
25
23
21
22
21
20
21
159
154
161
180
168
218
1,202
2,433
2,409
1,415
1,422
1,401
1,397
1,3971,4011,4221,4152,4092,4331,2022181681801611541592120212221232522273237424956636673808795102109116108127120125141167981161331571802042278097877367568568997824352612222402544957402052162282422562702180000000000001,8111,8622,56507,5396,7807,60807,2401,4571,557
       Property Plant Equipment 
1,267
1,167
1,588
1,478
1,478
1,341
2,204
1,825
1,825
1,531
1,548
0
0
0
0
0
0
0
0
0
0
0
0
47
105
97
89
82
75
71
128
127
139
128
117
164
344
315
285
256
248
228
207
186
176
158
139
121
102
87
72
144
120
106
104
113
97
105
98
91
84
76
69
62
55
52
45
38
31
26
21
16
11
14
12
10
11
10
9
10
148
143
150
169
157
207
215
249
235
1,415
224
213
210
2102132241,41523524921520715716915014314810910111012141116212631384552556269768491981059711310410612014472871021211391581761862072282482562853153441641171281391271287175828997105470000000000001,5481,5311,8251,8252,2041,3411,4781,4781,5881,1671,267
       Goodwill 
0
0
5,363
5,087
5,088
4,538
4,263
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000000000000000000000000000000000000000000000004,2634,5385,0885,0875,36300
       Intangible Assets 
0
0
0
5,087
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
171
164
158
152
146
139
133
127
121
115
108
102
96
90
83
77
71
65
59
52
46
40
35
30
25
20
18
15
13
10
8
5
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
90
0
0
0
0
0
0000090000000000000000000000000000000035810131518202530354046525965717783909610210811512112713313914615215816417100000000000000000005,087000
       Other Assets 
290
290
5,652
6,130
5,808
5,440
5,335
740
437
331
263
371
0
0
0
0
0
0
0
0
0
0
0
171
165
159
153
146
140
134
612
368
116
111
105
97
91
467
615
600
508
509
579
623
51
46
41
36
31
29
26
23
21
19
16
14
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
11
988
2,184
2,174
0
1,198
0
0
001,19802,1742,1849881111111111111111111111111111111111111111111111111111111111111416192123262931364146516235795095086006154679197105111116368612134140146153159165171000000000003712633314377405,3355,4405,8086,1305,652290290
> Total Liabilities 
646
611
701
640
640
530
811
1,868
1,869
2,472
3,096
1,010
3,990
0
0
0
4,965
0
5,103
5,298
4,965
5,794
5,157
469
193
80
515
683
599
135
352
516
346
292
333
349
571
473
1,225
847
522
673
731
650
942
510
380
338
327
350
152
226
312
235
237
170
187
217
181
118
127
166
180
253
370
548
652
732
811
968
1,114
1,348
1,664
1,680
1,671
1,837
2,043
2,695
2,808
942
825
464
359
336
7,435
5,501
5,368
6,789
4,748
4,539
4,086
7,082
3,520
3,5207,0824,0864,5394,7486,7895,3685,5017,4353363594648259422,8082,6952,0431,8371,6711,6801,6641,3481,1149688117326525483702531801661271181812171871702372353122261523503273383805109426507316735228471,225473571349333292346516352135599683515801934695,1575,7944,9655,2985,10304,9650003,9901,0103,0962,4721,8691,868811530640640701611646
   > Total Current Liabilities 
487
461
553
538
538
457
760
672
672
558
1,064
0
3,987
0
0
0
2,560
0
2,447
2,575
2,560
5,794
5,157
469
193
80
515
683
599
135
352
516
346
292
333
349
571
473
1,225
847
522
673
731
650
942
510
380
338
327
350
152
226
312
235
237
170
187
217
181
118
127
166
180
253
370
548
652
732
811
919
1,068
1,305
1,625
1,644
1,639
1,808
2,016
2,670
2,786
924
810
452
359
336
5,435
3,501
3,368
4,789
4,748
4,539
4,086
7,082
3,520
3,5207,0824,0864,5394,7484,7893,3683,5015,4353363594528109242,7862,6702,0161,8081,6391,6441,6251,3051,0689198117326525483702531801661271181812171871702372353122261523503273383805109426507316735228471,225473571349333292346516352135599683515801934695,1575,7942,5602,5752,44702,5600003,98701,064558672672760457538538553461487
       Short-term Debt 
227
127
154
0
167
147
152
0
83
60
190
0
0
0
0
0
1,164
0
0
0
1,164
4,045
4,444
-95
853
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
4
7
260
13
13
13
13
12
618
183
183
183
0
0
0
0
0
0
0
0
0
0
0
00000000000183183183618121313131326074100000000000000000000000000000000000000000000853-954,4444,0451,1640001,16400000190608301521471670154127227
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
4
7
10
13
13
13
13
12
618
183
183
183
0
0
0
0
0
0
0
0
0
0
0
00000000000183183183618121313131310741000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
244
212
325
291
290
231
521
478
478
451
721
0
133
0
0
0
69
0
194
186
69
197
273
95
84
67
479
371
547
135
352
352
346
169
141
98
408
361
602
355
339
436
521
165
138
184
29
69
164
111
39
85
156
135
115
82
56
46
111
42
101
103
39
33
76
151
152
118
78
54
66
148
126
253
116
63
153
741
91
161
268
232
290
289
2,058
426
237
1,079
1,748
1,288
871
4,213
2,803
2,8034,2138711,2881,7481,0792374262,0582892902322681619174115363116253126148665478118152151763339103101421114656821151351568539111164692918413816552143633935560236140898141169346352352135547371479678495273197691861940690001330721451478478521231290291325212244
       Other Current Liabilities 
16
122
74
133
80
80
87
111
8
46
153
0
2,542
0
0
0
1,328
0
1,281
1,349
1,004
1,231
2
95
109
13
37
313
51
5
26
164
170
292
333
349
571
473
1,225
847
522
237
210
485
803
326
351
269
163
239
113
140
156
101
122
88
131
171
70
76
26
63
141
219
294
397
500
613
734
864
998
1,150
1,239
1,379
1,510
1,732
1,851
1,917
2,076
580
359
37
69
46
3,378
3,075
3,131
3,710
3,000
3,251
3,214
2,868
717
7172,8683,2143,2513,0003,7103,1313,0753,3784669373595802,0761,9171,8511,7321,5101,3791,2391,15099886473461350039729421914163267670171131881221011561401132391632693513268034852102375228471,2254735713493332921701642655131337131099521,2311,0041,3491,28101,3280002,54201534681118780801337412216
   > Long-term Liabilities 
159
150
149
0
102
73
51
0
1,197
1,914
2,032
0
0
0
0
0
2,405
0
0
0
2,405
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
49
46
43
40
35
32
29
27
25
22
19
15
12
0
0
2,000
2,000
2,000
2,000
1,748
1,288
0
0
0
0001,2881,7482,0002,0002,0002,00000121519222527293235404346490000000000000000000000000000000000000000000000002,4050002,405000002,0321,9141,197051731020149150159
       Long term Debt 
159
150
149
102
84
73
51
1,196
1,671
1,914
2,032
0
3
0
0
0
2,405
0
2,656
2,723
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
49
46
43
40
35
32
29
27
25
22
19
15
12
0
0
0
0
0
0
0
0
0
0
0
000000000001215192225272932354043464900000000000000000000000000000000000000000000000002,7232,65602,405000302,0321,9141,6711,196517384102149150159
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
336
2,000
2,000
2,000
2,000
0
0
0
0
0
000002,0002,0002,0002,00033600000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,000
2,000
2,000
0
0
0
0
0
000002,0002,0002,0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
6,893
6,569
11,105
10,521
10,521
7,913
8,025
2,049
2,049
-274
-905
-639
0
0
0
0
-4,946
0
0
0
-4,946
-5,715
-5,062
2,360
2,203
1,917
813
301
2,648
2,393
3,660
3,342
2,710
2,477
2,099
3,926
3,744
3,362
2,623
2,146
1,836
1,395
1,404
1,162
704
2,327
1,910
1,698
1,151
1,780
1,893
1,736
2,527
1,938
1,283
883
1,146
3,142
2,483
1,880
1,205
630
159
423
240
-244
338
-236
-321
-129
-743
-724
-1,022
-1,207
-1,329
-1,021
-1,575
-1,864
-1,850
10,814
9,569
20,651
19,458
18,004
4,362
11,354
27,873
31,781
26,600
22,865
17,164
9,119
5,763
5,7639,11917,16422,86526,60031,78127,87311,3544,36218,00419,45820,6519,56910,814-1,850-1,864-1,575-1,021-1,329-1,207-1,022-724-743-129-321-236338-2442404231596301,2051,8802,4833,1421,1468831,2831,9382,5271,7361,8931,7801,1511,6981,9102,3277041,1621,4041,3951,8362,1462,6233,3623,7443,9262,0992,4772,7103,3423,6602,3932,6483018131,9172,2032,360-5,062-5,715-4,946000-4,9460000-639-905-2742,0492,0498,0257,91310,52110,52111,1056,5696,893
   Common Stock
58
58
60
62
62
62
63
64
64
66
68
0
83
0
0
0
99
0
100
100
99
100
100
708
711
713
713
713
732
732
743
745
747
750
754
778
782
16
16
16
16
16
16
16
16
17
18
19
19
21
22
22
24
25
25
26
32
32
32
32
32
37
38
49
55
56
63
71
107
142
165
178
219
1
1
96
0
14
14
4
4
6
6
6
6
9
16
26
26
26
26
27
2
2272626262616966664414140961121917816514210771635655493837323232323226252524222221191918171616161616161616782778754750747745743732732713713713711708100100991001000990008306866646463626262605858
   Retained Earnings -104,364-96,771-88,363-82,435-78,397-73,013-69,045-66,803-64,376-50,633-48,682-47,368-45,806-44,469-43,898-43,443-42,848-42,257-41,832-41,178-40,477-39,843-39,176-38,539-37,917-37,401-36,812-36,295-35,747-34,811-34,347-33,771-32,475-31,782-31,162-30,486-29,786-28,862-28,348-27,668-27,052-26,180-25,990-25,464-24,767-24,157-23,860-23,363-22,632-21,479-21,103-20,891-20,285-19,806-19,162-18,229-17,538-16,695-16,464-15,115-14,254-13,214-12,492-11,208-10,525-9,370-8,204-6,871-6,284-6,220-71,002-71,534-70,126000-70,12600000-64,370-63,026-59,5940-51,893-50,488-47,6440-45,628-42,808-41,559
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
55,295
67,937
68,134
0
0
0
0
0
0
0
0
0
0
000000000068,13467,93755,29500000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
48,394
49,319
56,673
0
58,103
58,339
59,856
0
61,579
62,686
63,397
-639
0
0
0
0
65,081
0
0
0
65,081
65,620
65,739
7,909
7,823
8,165
8,351
9,027
12,518
12,945
15,498
15,907
16,329
16,966
17,944
19,993
20,678
21,782
22,006
22,203
22,378
22,564
22,491
22,625
23,319
24,801
25,340
25,524
25,587
26,911
27,549
27,582
28,239
28,591
28,670
28,863
30,824
32,537
32,553
32,570
32,588
33,347
33,451
34,168
34,915
34,978
35,110
35,155
35,590
36,220
36,558
36,831
37,264
38,564
38,165
38,819
39,340
41,189
41,659
55,857
55,806
68,454
68,134
68,630
68,731
78,148
96,902
104,768
104,971
105,273
105,500
105,864
110,125
110,125105,864105,500105,273104,971104,76896,90278,14868,73168,63068,13468,45455,80655,85741,65941,18939,34038,81938,16538,56437,26436,83136,55836,22035,59035,15535,11034,97834,91534,16833,45133,34732,58832,57032,55332,53730,82428,86328,67028,59128,23927,58227,54926,91125,58725,52425,34024,80123,31922,62522,49122,56422,37822,20322,00621,78220,67819,99317,94416,96616,32915,90715,49812,94512,5189,0278,3518,1657,8237,90965,73965,62065,08100065,0810000-63963,39762,68661,579059,85658,33958,103056,67349,31948,394



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-74
Gross Profit-74-74
 
Operating Income (+$)
Gross Profit-74
Operating Expense-26,669
Operating Income-26,743-26,743
 
Operating Expense (+$)
Research Development20,721
Selling General Administrative6,022,173,000
Selling And Marketing Expenses-6,022,167,052
Operating Expense26,66926,669
 
Net Interest Income (+$)
Interest Income679
Interest Expense-0
Other Finance Cost-0
Net Interest Income679
 
Pretax Income (+$)
Operating Income-26,743
Net Interest Income679
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-25,967-27,519
EBIT - interestExpense = -26,743
-25,967
-25,967
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-26,743-25,967
Earnings Before Interest and Taxes (EBITDA)-26,669
 
After tax Income (+$)
Income Before Tax-25,967
Tax Provision-0
Net Income From Continuing Ops-23,758-25,967
Net Income-25,967
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses26,743
Total Other Income/Expenses Net776-679
 

Technical Analysis of Geovax
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Geovax. The general trend of Geovax is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Geovax's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of GeoVax Labs Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.82 < 1.82 < 1.82.

The bearish price targets are: .

Tweet this
GeoVax Labs Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of GeoVax Labs Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

GeoVax Labs Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of GeoVax Labs Inc. The current macd is -0.1853486.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Geovax price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Geovax. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Geovax price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
GeoVax Labs Inc Daily Moving Average Convergence/Divergence (MACD) ChartGeoVax Labs Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of GeoVax Labs Inc. The current adx is 20.22.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Geovax shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
GeoVax Labs Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of GeoVax Labs Inc. The current sar is 2.01820905.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
GeoVax Labs Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of GeoVax Labs Inc. The current rsi is 29.57. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 2/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending up: The RSI is trending up. +1
GeoVax Labs Inc Daily Relative Strength Index (RSI) ChartGeoVax Labs Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of GeoVax Labs Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Geovax price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
GeoVax Labs Inc Daily Stochastic Oscillator ChartGeoVax Labs Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of GeoVax Labs Inc. The current cci is -149.10116106.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
GeoVax Labs Inc Daily Commodity Channel Index (CCI) ChartGeoVax Labs Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of GeoVax Labs Inc. The current cmo is -45.35503776.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
GeoVax Labs Inc Daily Chande Momentum Oscillator (CMO) ChartGeoVax Labs Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of GeoVax Labs Inc. The current willr is -89.99857122.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
GeoVax Labs Inc Daily Williams %R ChartGeoVax Labs Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of GeoVax Labs Inc.

GeoVax Labs Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of GeoVax Labs Inc. The current atr is 0.19577065.

GeoVax Labs Inc Daily Average True Range (ATR) ChartGeoVax Labs Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of GeoVax Labs Inc. The current obv is 63,164,566.

GeoVax Labs Inc Daily On-Balance Volume (OBV) ChartGeoVax Labs Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of GeoVax Labs Inc. The current mfi is 43.51.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
GeoVax Labs Inc Daily Money Flow Index (MFI) ChartGeoVax Labs Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for GeoVax Labs Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-20RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-12-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-31BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

GeoVax Labs Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of GeoVax Labs Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5029.573
Ma 20Greater thanMa 501.834
Ma 50Greater thanMa 1002.110
Ma 100Greater thanMa 2003.573
OpenGreater thanClose1.550
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Geovax with someone you think should read this too:
  • Are you bullish or bearish on Geovax? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Geovax? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about GeoVax Labs Inc

I send you an email if I find something interesting about GeoVax Labs Inc.


Comments

How you think about this?

Leave a comment

Stay informed about GeoVax Labs Inc.

Receive notifications about GeoVax Labs Inc in your mailbox!